Yield of sputum microbiological examination in patients hospitalized for exacerbations of chronic obstructive pulmonary disease with purulent sputum
- PMID: 16675894
- DOI: 10.1159/000093158
Yield of sputum microbiological examination in patients hospitalized for exacerbations of chronic obstructive pulmonary disease with purulent sputum
Abstract
Background: Whether sputum microbiological examination should be performed systematically in hospitalized patients with chronic obstructive pulmonary disease (COPD) exacerbations remains unclear.
Objectives: To assess the yield of sputum microbiological examination in COPD patients hospitalized in a medical ward for an acute exacerbation with purulent sputum.
Methods: Two hundred consecutive exacerbations in 118 patients were studied. Patients underwent sputum microbiological examination on admission and baseline lung function tests and CT scans were recorded. Factors associated with positive culture were analyzed.
Results: Sputum culture was positive (>or=10(7) CFU/ml) in 59% of samples, Haemophilus influenzae and Streptococcus pneumoniae being the most frequent pathogens. Factors associated with positive culture were bronchiectasis, long-term oxygen therapy and low FEV1. Pseudomonas spp. were found in 8.5% of all patients, who all had a FEV1<50% of predicted and were older. Only 25% of sputum samples satisfied all quality criteria. Sputum culture was positive in a high proportion of these samples (80.5%), but also in one half of samples with >25 leukocytes but >10 epithelial cells per field. Microbiological results induced a change in antibiotic therapy in 43.9% of cases with both quality criteria but also in 25.2% of cases with only one quality criterion. Finally, a predominant aspect after Gram stain was found in all positive samples.
Conclusions: These data suggest that sputum microbiological examination with direct examination and leukocyte count should be performed routinely in patients hospitalized for COPD exacerbations with purulent sputum, especially when FEV1 is less than 50% predicted and in patients with bronchiectasis.
Copyright (c) 2007 S. Karger AG, Basel.
Comment in
-
The clinician through the looking glass: sputum microbiology in COPD exacerbations.Respiration. 2007;74(1):13-4. doi: 10.1159/000094886. Epub 2006 Aug 3. Respiration. 2007. PMID: 16888368 No abstract available.
Similar articles
-
Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease.Arch Intern Med. 2005 Apr 25;165(8):891-7. doi: 10.1001/archinte.165.8.891. Arch Intern Med. 2005. PMID: 15851640
-
Predictors of positive sputum cultures in exacerbations of chronic obstructive pulmonary disease.Respirology. 2009 Nov;14(8):1114-20. doi: 10.1111/j.1440-1843.2009.01615.x. Epub 2009 Sep 16. Respirology. 2009. PMID: 19761538
-
Sputum bacteriology in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease in Taiwan with an emphasis on Klebsiella pneumoniae and Pseudomonas aeruginosa.Respirology. 2007 Jan;12(1):81-7. doi: 10.1111/j.1440-1843.2006.00999.x. Respirology. 2007. PMID: 17207030
-
[The role of macrolides in treatment of exacerbations of chronic obstructive pulmonary disease].Pol Merkur Lekarski. 2010 Apr;28(166):311-4. Pol Merkur Lekarski. 2010. PMID: 20491344 Review. Polish.
-
[Antibiotics for acute exacerbations of chronic obstructive pulmonary disease (COPD)].Med Mal Infect. 2006 Nov-Dec;36(11-12):706-17. doi: 10.1016/j.medmal.2006.05.011. Epub 2006 Jul 12. Med Mal Infect. 2006. PMID: 16839731 Review. French.
Cited by
-
Antibiotic Prescription for COPD Exacerbations Admitted to Hospital: European COPD Audit.PLoS One. 2015 Apr 23;10(4):e0124374. doi: 10.1371/journal.pone.0124374. eCollection 2015. PLoS One. 2015. PMID: 25905726 Free PMC article.
-
Bacterial infections in acute exacerbation of chronic obstructive pulmonary disease: a systematic review and meta-analysis.Infection. 2020 Feb;48(1):19-35. doi: 10.1007/s15010-019-01350-1. Epub 2019 Sep 3. Infection. 2020. PMID: 31482316
-
Clinical characteristics of patients with chronic obstructive pulmonary disease with comorbid bronchiectasis: a systemic review and meta-analysis.Int J Chron Obstruct Pulmon Dis. 2015 Jul 28;10:1465-75. doi: 10.2147/COPD.S83910. eCollection 2015. Int J Chron Obstruct Pulmon Dis. 2015. PMID: 26251586 Free PMC article.
-
Quantitative computed tomography features and clinical manifestations associated with the extent of bronchiectasis in patients with moderate-to-severe COPD.Int J Chron Obstruct Pulmon Dis. 2018 May 1;13:1421-1431. doi: 10.2147/COPD.S157953. eCollection 2018. Int J Chron Obstruct Pulmon Dis. 2018. PMID: 29750028 Free PMC article.
-
Guidelines for the management of adult lower respiratory tract infections--full version.Clin Microbiol Infect. 2011 Nov;17 Suppl 6(Suppl 6):E1-59. doi: 10.1111/j.1469-0691.2011.03672.x. Clin Microbiol Infect. 2011. PMID: 21951385 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous